Author Archives: Rich Haridy

Psilocybin clinical trial confirms safety of group psychedelic sessions

Posted on by

Subjects in the trial were given a private space in a larger room and given eye masks and earplugs while up to six people were simultaneously administered psilocybin

A new study published in the The Journal of Psychopharmacology is reporting the results of a large clinical trial testing the short- and long-term safety of administering psilocybin in a group setting. Exploring the psychedelic therapy in groups of up to six people, the trial found no detrimental effects from simultaneous administration of the drug.

Continue Reading

Category: Science

Tags: , , ,

Continue reading Psilocybin clinical trial confirms safety of group psychedelic sessions→

Dementia-preventing nasal spray moves to human trials

Posted on by

A novel nasal spray combines a common antibiotic with a well-known antioxidant and human trials are set to begin soon

Scientists from Osaka City University are reporting successful preclinical tests of a novel nasal spray designed to prevent the neurodegeneration associated with dementia. The spray combines two cheap, pre-existing drugs and was found to improve cognitive function in several different mouse models of dementia.

Continue Reading

Category: Science

Tags: , , , ,

Continue reading Dementia-preventing nasal spray moves to human trials→

New patent-free COVID vaccine developed as “gift to the world”

Posted on by

A new COVID-19 vaccine, developed by researchers from the Texas Children’s Hospital and Baylor College of Medicine, is being offered patent-free to vaccine manufacturers across the world. Human trials have shown the vaccine to be safe and effective, wi… Continue reading New patent-free COVID vaccine developed as “gift to the world”→

Highlights from a landmark year in psychedelic science

Posted on by

As we get closer and closer to a world where psychedelic medicines are widely used in a variety of therapeutic ways, the last 12 months saw some incredible advances in the field of psychedelic science. From the first published data out of large-scale c… Continue reading Highlights from a landmark year in psychedelic science→

FDA authorization of Merck COVID pill called “worst decision in its history”

Posted on by

The US Food and Drug Administration (FDA) has issued emergency use authorization to a second oral COVID-19 treatment. Called molnupiravir the new drug is not as effective as Pfizer’s recently approved COVID antiviral pill, and many experts suggest the … Continue reading FDA authorization of Merck COVID pill called “worst decision in its history”→